Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.42 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.41 |
| ▸ | IDE | P14735 | 3/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 1/20 | 0.41 |
| ▸ | FCER2 | P06734 | 1/20 | 0.41 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5966484 | 0.90 | BIRC2 (0.44) | BIRC2SSTR3 | |
| SCHEMBL5966598 | 0.87 | NPY4R (0.53) | CTSLBIRC2IDENPY1RNPY4R | |
| SCHEMBL5966605 | 0.87 | NPY4R (0.53) | CTSLBIRC2IDENPY1RNPY4R | |
| SCHEMBL5966575 | 0.83 | FNTA (0.49) | CTSL | |
| SCHEMBL5966480 | 0.83 | BIRC2 (0.41) | BIRC2IDEFCER2SSTR3 | |
| SCHEMBL5966537 | 0.81 | CTSS (0.53) | CTSLKISS1RFCER2 | |
| SCHEMBL5966493 | 0.80 | CTSS (0.52) | CTSL | |
| SCHEMBL5966592 | 0.80 | SSTR3 (0.47) | KISS1RNPY1RNPY4RSSTR3 | |
| SCHEMBL5966559 | 0.78 | CTSS (0.53) | CTSLKISS1RFCER2 | |
| SCHEMBL5966565 | 0.77 | CTSS (0.49) | CTSLSSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2006-06-15 | — | — | US | disclosed |
| EP-1409540-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-21 | — | — | EP | disclosed |
| WO-2002026774-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060128613-A1 | Melanocortin receptor ligands | MC3R, MC4R, MC1R | CTSL 3363/4885KISS1R 83/4885BIRC2 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.